Waters Co. (WAT) SVP Michael C. Harrington Sells 1,131 Shares of Stock

Waters Co. (NYSE:WAT) SVP Michael C. Harrington sold 1,131 shares of the business’s stock in a transaction that occurred on Friday, December 14th. The stock was sold at an average price of $189.53, for a total transaction of $214,358.43. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

NYSE WAT opened at $184.58 on Tuesday. The company has a market cap of $14.31 billion, a P/E ratio of 24.64, a PEG ratio of 2.26 and a beta of 0.97. Waters Co. has a 52 week low of $167.93 and a 52 week high of $220.20. The company has a debt-to-equity ratio of 0.61, a current ratio of 6.63 and a quick ratio of 5.93.

Waters (NYSE:WAT) last released its earnings results on Tuesday, October 23rd. The medical instruments supplier reported $1.92 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.02. The company had revenue of $578.02 million for the quarter, compared to the consensus estimate of $587.43 million. Waters had a net margin of 2.32% and a return on equity of 30.68%. Waters’s revenue was up 2.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.77 EPS. Research analysts forecast that Waters Co. will post 8.06 earnings per share for the current fiscal year.

Several research firms recently commented on WAT. JPMorgan Chase & Co. lowered shares of Waters from a “neutral” rating to an “underweight” rating and reduced their price objective for the stock from $185.00 to $180.00 in a research note on Wednesday, December 12th. Goldman Sachs Group lowered shares of Waters from a “neutral” rating to a “sell” rating and set a $200.83 price objective for the company. in a research note on Sunday, December 9th. ValuEngine upgraded shares of Waters from a “hold” rating to a “buy” rating in a research note on Tuesday, November 27th. UBS Group reduced their price objective on shares of Waters from $210.00 to $200.00 and set a “neutral” rating for the company in a research note on Wednesday, October 24th. Finally, Barclays reduced their price objective on shares of Waters from $200.00 to $190.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 24th. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $206.12.

A number of large investors have recently added to or reduced their stakes in the business. Cambridge Investment Research Advisors Inc. grew its position in Waters by 19.8% during the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 1,720 shares of the medical instruments supplier’s stock worth $335,000 after purchasing an additional 284 shares during the last quarter. Stone Ridge Asset Management LLC grew its position in Waters by 14.5% during the 3rd quarter. Stone Ridge Asset Management LLC now owns 2,369 shares of the medical instruments supplier’s stock worth $461,000 after purchasing an additional 300 shares during the last quarter. Candriam Luxembourg S.C.A. grew its position in Waters by 3.1% during the 3rd quarter. Candriam Luxembourg S.C.A. now owns 10,306 shares of the medical instruments supplier’s stock worth $2,006,000 after purchasing an additional 314 shares during the last quarter. Raymond James Financial Services Advisors Inc. grew its position in Waters by 5.8% during the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 7,118 shares of the medical instruments supplier’s stock worth $1,378,000 after purchasing an additional 391 shares during the last quarter. Finally, Ledyard National Bank grew its position in Waters by 38.3% during the 3rd quarter. Ledyard National Bank now owns 1,660 shares of the medical instruments supplier’s stock worth $323,000 after purchasing an additional 460 shares during the last quarter. 92.25% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: “Waters Co. (WAT) SVP Michael C. Harrington Sells 1,131 Shares of Stock” was published by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are viewing this article on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this article can be viewed at https://www.thelincolnianonline.com/2018/12/18/waters-co-wat-svp-michael-c-harrington-sells-1131-shares-of-stock.html.

About Waters

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Recommended Story: What is Considered a Good Return on Equity (ROE)?

Insider Buying and Selling by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply